Advanced search
Publication Cover
Hematology Volume 18, 2013 - Issue 4
Submit an article Journal homepage
1,079
Views
7
CrossRef citations to date
0
Altmetric
CHRONIC MYELOID LEUKEMIA

The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells

Süreyya BozkurtDepartment of Basic OncologyInsitute of Oncology, Hacettepe University, Ankara, TurkeyCorrespondence[email protected]
,
Tülin ÖzkanDepartment of Medical BiologyFaculty of Medicine, Ankara University, Ankara, Turkey
,
Füsun ÖzmenDepartment of Basic OncologyInsitute of Oncology, Hacettepe University, Ankara, Turkey
,
Yusuf BaranDepartment of Molecular Biology and GeneticsFaculty of Science, İzmir Institute of Technology, İzmir, Turkey
,
Asuman SunguroğluDepartment of Medical BiologyFaculty of Medicine, Ankara University, Ankara, Turkey
&
Emin KansuDepartment of Basic OncologyInsitute of Oncology, Hacettepe University, Ankara, Turkey
Pages 217-223 | Published online: 15 Nov 2013

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hong Zhang, Peiran Wang, Ting Song, Uwituze Laura Bonnette & Zhichao Zhang. (2021) Screening and identification of key genes in imatinib-resistant chronic myelogenous leukemia cells: a bioinformatics study. Hematology 26:1, pages 408-414.
Read now

Articles from other publishers (6)

Qiting Zhang, Ziyan Wang, Xinyuan Chen, Haoxiang Qiu, Yifan Gu, Ning Wang, Tao Wang, Ze Wang, Huabin Ma, Yufen Zhao & Bin Zhang. (2021) 8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1. International Journal of Molecular Sciences 22:11, pages 5516.
Crossref
Federica Loscocco, Giuseppe Visani, Sara Galimberti, Antonio Curti & Alessandro Isidori. (2019) BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia. Frontiers in Oncology 9.
Crossref
Jane Bugler, Ross Kinstrie, Mary T. Scott & David Vetrie. (2019) Epigenetic Reprogramming and Emerging Epigenetic Therapies in CML. Frontiers in Cell and Developmental Biology 7.
Crossref
Nizar M. Mhaidat, Fawzi M. Al Sheyab, Ahmad M. Zyoud, Karem H. Alzoubi, Omar F. Khabour, Nisreen A. AL-Quraan, Khaldon Bodoor & Wesam M. Al Khateeb. (2019) Study the epigenetic down-regulation of Bim on colorectal cancer chemotherapy response. Journal of King Saud University - Science 31:3, pages 308-313.
Crossref
Steffen Koschmieder & David Vetrie. (2018) Epigenetic dysregulation in chronic myeloid leukaemia: A myriad of mechanisms and therapeutic options. Seminars in Cancer Biology 51, pages 180-197.
Crossref
Aijun Shen, Lu Wang, Min Huang, Jingya Sun, Yi Chen, Yan-Yan Shen, Xinying Yang, Xin Wang, Jian Ding & Meiyu Geng. (2015) c-Myc Alterations Confer Therapeutic Response and Acquired Resistance to c-Met Inhibitors in MET-Addicted Cancers. Cancer Research 75:21, pages 4548-4559.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.